A new mode of ventilation for interventional pulmonology. A case with EBUS-TBNA and debulking
Lung cancer is still underdiagnosed mainly due to lack of symptoms. Most patients are diagnosed in a late stage where unfortunately only systematic therapy can be applied. Fortunately in the last five years several novel therapies and combinations have emerged. However; in certain situations local t...
Main Authors: | Paul Zarogoulidis, Haidong Huang, Chong Bai, Christoforos Kosmidis, Konstantinos Porpodis, Anastasios Kallianos, Lemonia Veletza, Georgia Trakada, Naim Benhassen, Wolfgang Hohenforst-Schmidt |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Respiratory Medicine Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007117303271 |
Similar Items
-
Possible adverse effects of immunotherapy in non-small cell lung cancer; treatment and follow-up of three cases
by: Paul Zarogoulidis, et al.
Published: (2017-01-01) -
Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma
by: Paul Zarogoulidis, et al.
Published: (2017-01-01) -
Hamman's syndrome (spontaneous pneumomediastinum presenting as subcutaneous emphysema): A rare case of the emergency department and review of the literature
by: Konstantinos Grapatsas, et al.
Published: (2018-01-01) -
“Liquid elbows” due to afatinib administration
by: Paul Zarogoulidis, et al.
Published: (2017-01-01) -
Re-biopsy after relapse of targeted therapy. T790M after epidermal growth factor mutation, where and why based on a case series
by: Paul Zarogoulidis, et al.
Published: (2017-01-01)